Broker Recommendations
Morgan Stanley upgrades Haleon on sector leading exposure to defensive product categories
Analysts at Morgan Stanley upgraded their recommendation for shares of consumer healthcare outfit Haleon.
Primary Health Properties still the preferred bidder for Assura, says Shore Capital
Shore Capital has kept a 'buy' rating on healthcare real estate firm Primary Health Properties, saying the company is "still in the mix" over the bidding war for Assura and remains the preferable alternative to the latest offer from KKR and Stonepeak.
Sage should be resilient amid macro uncertainty, says Citi
Citi has reiterated a 'buy' rating for enterprise software giant Sage ahead of its interim results next week, saying that the company's "drivers of resilience" were solid despite an uncertain macro environment.
Berenberg hikes target price on Next
Analysts at Berenberg hiked their target price on retailer Next from 13,400. 0p to 14,700. 0p on Friday, citing upside risks to its Q2 estimates.
Berenberg starts coverage of Telecom Plus at ‘buy’
Berenberg initiated coverage of Telecom Plus on Thursday with a ‘buy’ rating and 2,600p price target as it argued it was a "gem" that has "fallen through the cracks".
Canaccord Genuity initiates coverage on Eleco at 'buy'
Analysts at Canaccord Genuity initiated coverage on Eleco with a 'buy' rating and 176. 0p target price on Thursday as it wondered if the firm was poised to become "the next UK SaaS champion?".
UBS upgrades Weir to ‘buy’, shares rally
Weir Group shot higher on Thursday after UBS upgraded the shares to ‘buy’ from ‘neutral’ and hiked the price target to 2,850p from 2,250p.
Berenberg lowers target price on Synthomer
Analysts at Berenberg lowered their target price on chemicals Synthomer from 150. 0p to 120. 0p on Wednesday, stating the group was not yet divested of balance-sheet problems.
Trainline shares drop, but Shore Capital sticks with 'buy' rating
Trainline's share price was in reverse on Wednesday after final results from the ticketing platform failed to reassure investors, though broker Shore Capital chose to stick with its positive rating on the stock.
Canaccord Genuity raises target price on Taseko Mines
Analysts at Canaccord Genuity lowered their target price on copper producer Taseko Mines from 305. 0p to 290. 0p on Tuesday as it updated its model on the stock following the group's Q125 numbers.
Berenberg reiterates 'buy' rating on Morgan Sindall
Analysts at Berenberg reiterated their 'buy' rating on construction firm Morgan Sindall on Tuesday after the group issued a trading update.
Berenberg reiterates 'buy' rating on Entain following Q1 update
Analysts at Berenberg reiterated their 'buy' rating and 1,100. 0p target price on bookmaker Entain, noting that momentum was continuing to build.
Berenberg lowers target price on Glencore
Analysts at Berenberg lowered their target price on mining giant Glencore from 400. 0p to 380. 0p on Thursday after the firm's 2025 started "on a soft note".
Canaccord Genuity lowers target price on Arrow Exploration
Analysts at Canaccord Genuity lowered their target price on Arrow Exploration from 32. 0p to 28. 0p on Thursday as it took a "more cautious approach" to the firm's production profile.
Berenberg reiterates 'buy' rating on Warpaint London
Analysts at Berenberg reiterated their 'buy' rating and 700. 0p target price on makeup business Warpaint London on Wednesday, stating it was confident in the group's outlook despite Q1 turbulence.
Canaccord Genuity hikes target price on Plus500
Analysts at Canaccord Genuity raised their target price on online trading services Plus500 from 2,650. 0p to 2,764. 0p on Wednesday, stating that it expects to see "a bumper Q2" trading performance.
Canaccord Genuity slightly lowers target price on Hochschild Mining
Analysts at Canaccord Genuity slightly lowered their target price on precious metals group Hochschild Mining from 370. 0p to 365. 0p on Tuesday following a "slower than expected" first half trading performance.
RBC Capital downgrades Ashtead, slashes price target
RBC Capital Markets downgraded equipment rental firm Ashtead on Tuesday to ‘sector perform’ from ‘outperform’ and slashed the price target to 4,125p from 6,750p as it factored in a slowdown.
Berenberg reiterates 'buy' rating on Yellow Cake
Analysts at Berenberg took a fresh look at uranium projects investor Yellow Cake on Monday following its quarterly net asset value update for the fiscal year-end, in which it revealed it had a period-end NAV of $1. 41bn at the end of March.
RBC Capital starts coverage of Cohort, Chemring and Qinetiq
RBC Capital Markets initiated coverage of SMID UK defence companies Cohort, Chemring and Qinetiq on Monday, with a preference for products over services.